Przejdź do treści
HPB-ALL
Chusteczka
Peripheral blood
Choroba
Precursor T-cell acute lymphoblastic leukemia
Miejsce przerzutów
Peripheral blood (systemic T-ALL)
Synonimy
HPB/ALL, HPBALL, FCCH1018

Dokumenty

HPB-ALL

Cell line · Numer produktu 302895

HPB-ALL to ludzka linia komórkowa ostrej białaczki limfoblastycznej z komórek prekursorowych T (T-ALL), wyizolowana z krwi obwodowej 14-letniego japońskiego chłopca...

€430.00bez podatku i kosztów wysyłki

Dostosowanie / Zalecenia

W magazynie
Lot
Polecane (najświeższa partia)
  • CoA
1

01Informacje ogólne

Opis

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Chusteczka
Peripheral blood
Choroba
Precursor T-cell acute lymphoblastic leukemia
Miejsce przerzutów
Peripheral blood (systemic T-ALL)
Zastosowania
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Synonimy
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Klasyfikacja

Organizm
Człowiek
Seks
Mężczyzna
Właściwości związane ze wzrostem
Zawieszenie
Poziom bezpieczeństwa biologicznego
1

03Cechy charakterystyczne

Morfologia
Lymphoblast-like
Typ komórki
T-cell
Czas podwojenia
~50 hours

04Identyfikatory

Źródło
HPB-ALL (Cytion catalog number 302895)
Numer identyfikacji podatkowej NCBI
9606
Cellosaurus
CVCL_1820

05Ekspresja i podatność

Profil mutacji
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Postępowanie i hodowla

Pożywka hodowlana
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Suplementy
Supplement the medium with 10% FBS
Odczynnik dysocjacyjny
dilution
Hodowla komórek w subkulturze
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Współczynnik podziału
1 : 10 split
Gęstość wysiewu
3-5*10^5/ml
Odnawianie płynów
Subculture : 2 times/week
Rozmrażanie i hodowla
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Kontrola jakości i kriokonserwacja

Pożywka do zamrażania
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Warunki przechowywania

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Warunki wysyłki

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Darczyńca

Wiek dawcy
14 years
Pochodzenie etniczne
Japanese

10Szczegóły produktu

Tabela składu